To investigate the mechanism through which UPF1 influences NPC cell viability, rescue experiments were conducted using pharmacological activator or inhibitors targeting COX-2, p38 MAPK or the JAK2/STAT3 pathway. The gene discussed is JAK2; the disease is nasopharyngeal carcinoma.